Glycosylated Peptide Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Glycosylated Peptide Market to 2027 - Global Analysis and Forecasts By Product (Erythropoietin, Monoclonal Antibodies, Others); Application ( Blood Diseases, Oncology, Others) and Geography

Report Code: TIPRE00003839 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Peptide glycosylation is a covalent modification that have potential to improve the physicochemical properties of peptides. It offers some of the advantages such as targeting specific tissues and organs, increased metabolic stability, increased bioavailability, enhanced receptor binding, reduction in clearance rates and others. These are used in the medical application to treat blood disorders, cancer and others.

MARKET DYNAMICS
The glycosylated peptide market is expected to rise during the forecast period owing to the key factors such as rise in the biopharmaceutical industry, rising expenditure of the research and development activities, and others. The rising prevalence of cancer and genetic disorders are likely to create opportunities for the development of more products during the forecast period.

MARKET SCOPE
The "Global Glycosylated Peptide Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by product, application and geography. The global glycosylated peptide market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global glycosylated peptide market is segmented on the basis of product and application and end user. Based on the product the market is classified as erythropoietin, monoclonal antibodies and others. On the basis of application the market is segmented as blood diseases, oncology and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global glycosylated peptide market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The glycosylated peptide market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting glycosylated peptide market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the glycosylated peptide market in these regions.

MARKET PLAYERS
The reports cover key developments in the glycosylated peptide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from glycosylated peptide market are anticipated to lucrative growth opportunities in the future with the rising demand for glycosylated peptide market in the global market. Below mentioned is the list of few companies engaged in the glycosylated peptide market.

The report also includes the profiles of key glycosylated peptide market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH (a Novartis Division)
  • Pfizer Inc.
  • F. Hoffmann-LA Roche Ltd
  • Celltrion Inc
  • Avenit AG
  • Dr. Reddy's laboratories ltd.
  • JPT Peptide Technologies
  • CPC Scientific Inc.
  • Sussex Research Laboratories Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glycosylated Peptide Market - By Product
1.3.2 Glycosylated Peptide Market - By Application
1.3.3 Glycosylated Peptide Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. GLYCOSYLATED PEPTIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. GLYCOSYLATED PEPTIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. GLYCOSYLATED PEPTIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. GLYCOSYLATED PEPTIDE - GLOBAL MARKET OVERVIEW
6.2. GLYCOSYLATED PEPTIDE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. GLYCOSYLATED PEPTIDE MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ERYTHROPOIETIN
7.3.1. Overview
7.3.2. Erythropoietin Market Forecast and Analysis
7.4. MONOCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Monoclonal Antibodies Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. GLYCOSYLATED PEPTIDE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BLOOD DISEASES
8.3.1. Overview
8.3.2. Blood Diseases Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. GLYCOSYLATED PEPTIDE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Glycosylated Peptide Market Overview
9.1.2 North America Glycosylated Peptide Market Forecasts and Analysis
9.1.3 North America Glycosylated Peptide Market Forecasts and Analysis - By Product
9.1.4 North America Glycosylated Peptide Market Forecasts and Analysis - By Application
9.1.5 North America Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Glycosylated Peptide Market
9.1.5.1.1 United States Glycosylated Peptide Market by Product
9.1.5.1.2 United States Glycosylated Peptide Market by Application
9.1.5.2 Canada Glycosylated Peptide Market
9.1.5.2.1 Canada Glycosylated Peptide Market by Product
9.1.5.2.2 Canada Glycosylated Peptide Market by Application
9.1.5.3 Mexico Glycosylated Peptide Market
9.1.5.3.1 Mexico Glycosylated Peptide Market by Product
9.1.5.3.2 Mexico Glycosylated Peptide Market by Application
9.2. EUROPE
9.2.1 Europe Glycosylated Peptide Market Overview
9.2.2 Europe Glycosylated Peptide Market Forecasts and Analysis
9.2.3 Europe Glycosylated Peptide Market Forecasts and Analysis - By Product
9.2.4 Europe Glycosylated Peptide Market Forecasts and Analysis - By Application
9.2.5 Europe Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Glycosylated Peptide Market
9.2.5.1.1 Germany Glycosylated Peptide Market by Product
9.2.5.1.2 Germany Glycosylated Peptide Market by Application
9.2.5.2 France Glycosylated Peptide Market
9.2.5.2.1 France Glycosylated Peptide Market by Product
9.2.5.2.2 France Glycosylated Peptide Market by Application
9.2.5.3 Italy Glycosylated Peptide Market
9.2.5.3.1 Italy Glycosylated Peptide Market by Product
9.2.5.3.2 Italy Glycosylated Peptide Market by Application
9.2.5.4 Spain Glycosylated Peptide Market
9.2.5.4.1 Spain Glycosylated Peptide Market by Product
9.2.5.4.2 Spain Glycosylated Peptide Market by Application
9.2.5.5 United Kingdom Glycosylated Peptide Market
9.2.5.5.1 United Kingdom Glycosylated Peptide Market by Product
9.2.5.5.2 United Kingdom Glycosylated Peptide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Glycosylated Peptide Market Overview
9.3.2 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis
9.3.3 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Glycosylated Peptide Market
9.3.5.1.1 Australia Glycosylated Peptide Market by Product
9.3.5.1.2 Australia Glycosylated Peptide Market by Application
9.3.5.2 China Glycosylated Peptide Market
9.3.5.2.1 China Glycosylated Peptide Market by Product
9.3.5.2.2 China Glycosylated Peptide Market by Application
9.3.5.3 India Glycosylated Peptide Market
9.3.5.3.1 India Glycosylated Peptide Market by Product
9.3.5.3.2 India Glycosylated Peptide Market by Application
9.3.5.4 Japan Glycosylated Peptide Market
9.3.5.4.1 Japan Glycosylated Peptide Market by Product
9.3.5.4.2 Japan Glycosylated Peptide Market by Application
9.3.5.5 South Korea Glycosylated Peptide Market
9.3.5.5.1 South Korea Glycosylated Peptide Market by Product
9.3.5.5.2 South Korea Glycosylated Peptide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Glycosylated Peptide Market Overview
9.4.2 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis
9.4.3 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Glycosylated Peptide Market
9.4.5.1.1 South Africa Glycosylated Peptide Market by Product
9.4.5.1.2 South Africa Glycosylated Peptide Market by Application
9.4.5.2 Saudi Arabia Glycosylated Peptide Market
9.4.5.2.1 Saudi Arabia Glycosylated Peptide Market by Product
9.4.5.2.2 Saudi Arabia Glycosylated Peptide Market by Application
9.4.5.3 U.A.E Glycosylated Peptide Market
9.4.5.3.1 U.A.E Glycosylated Peptide Market by Product
9.4.5.3.2 U.A.E Glycosylated Peptide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Glycosylated Peptide Market Overview
9.5.2 South and Central America Glycosylated Peptide Market Forecasts and Analysis
9.5.3 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Product
9.5.4 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Glycosylated Peptide Market
9.5.5.1.1 Brazil Glycosylated Peptide Market by Product
9.5.5.1.2 Brazil Glycosylated Peptide Market by Application
9.5.5.2 Argentina Glycosylated Peptide Market
9.5.5.2.1 Argentina Glycosylated Peptide Market by Product
9.5.5.2.2 Argentina Glycosylated Peptide Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. GLYCOSYLATED PEPTIDE MARKET, KEY COMPANY PROFILES
11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANDOZ INTERNATIONAL GMBH (A NOVARTIS DIVISION)
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. F. HOFFMANN-LA ROCHE LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CELLTRION INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. AVENIT AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. DR. REDDY’S LABORATORIES LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JPT PEPTIDE TECHNOLOGIES.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CPC SCIENTIFIC INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BIO-SYNTHESIS INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd
2. Sandoz International GmbH (a Novartis Division)
3. Pfizer Inc.
4. F. Hoffmann-LA Roche Ltd
5. Celltrion Inc
6. Avenit AG
7. Dr. Reddy's laboratories ltd.
8. JPT Peptide Technologies
9. CPC Scientific Inc.
10. Sussex Research Laboratories Inc.